DURECT Corporation to Present Preliminary Data from the Ongoing DUR-928 Alcoholic Hepatitis Phase 2a Trial and Report First Quarter 2019 Financial Results

Friday, May 3, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Call will feature discussions by KOLs Steven Flamm, M.D.. Tarek I. Hassanein, M.D., and Paul Kwo, M.D.

Conference Call and Webcast with Slides

Wednesday, May 8th at 8:30 a.m. Eastern Time/5:30 a.m. Pacific Time

Toll Free: 

888-882-4478

International:

323-794-2590

Conference ID: 

7156796

Webcast: 

http://public.viavid.com/index.php?id=134476



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store